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Non-woven textile mesh from polyglycolic acid (PGA) was found 
as a proper material for chondrocyte adhesion but worse for their 
proliferation. Neither hyaluronic acid nor chitosan nor polyvinyl 
alcohol (PVA) increased chondrocyte adhesion. However, 
chondrocyte proliferation suffered from acidic byproducts of PGA 
degradation. However, the addition of PVA and/or chitosan into a 
wet-laid non-woven textile mesh from PGA improved chondrocyte 
proliferation seeded in vitro on the PGA-based composite scaffold 
namely due to a diminished acidification of their 
microenvironment. This PVA/PGA composite mesh used in 
combination with a proper hydrogel minimized the negative 
effect of PGA degradation without dropping positive parameters 
of the PGA wet-laid non-woven textile mesh. In fact, presence of 
PVA and/or chitosan in the PGA-based wet-laid non-woven textile 
mesh even advanced the PGA-based wet-laid non-woven textile 
mesh for chondrocyte seeding and artificial cartilage production 
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 Cells seeded in a biodegradable scaffold that 
slowly dissipates and is gradually replaced by new 
functional tissue, this is a promising approach in 
regenerative medicine. Implantation of such an artificial 
tissue, namely artificial cartilage based on autologous 
chondrocytes, is already currently applied in clinical 
practice for osteoarthritis treatment. Three-dimensional 
highly porous and preferentially fibrous constructs are 
inevitable in modern tissue engineering. These scaffolds 
grant the cells not only with suitable environment for 
their proliferation and differentiation, but also with a 
proper mechanical and morphological support. Several 
hydrogels from biopolymers have been reported to create 
suitable environment for chondrocytes and to provide 
three-dimensional immobilization of the cells (Benya and 
Shaffer 1982, Brittberg et al. 1997, Radice et al. 2000, 
Drury and Mooney 2003, Ng et al. 2005). Despite many 
positive features of hydrogels, several serious limitations 
constrain them for broader application. Optimal 
biomechanical properties belong among the most 
significant shortcomings. Consequently, development of 
more favorable scaffolds fully complying with both 
biocompatibility and biomechanical requirements is a key 
task of modern tissue engineering.  
 Application of composite scaffolds that are 
formed, besides of hydrogels, also from other compounds 
like biocompatible polymers seems to be a promising 
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approach. A number of biodegradable polymers were 
reported. Polyglycolic acid (PGA), known as a resorbable 
suture in surgery and as ligament fixation in orthopedics, 
is frequently used (Freed et al. 1994, Rokkanen et al. 
2000, Schaefer et al. 2000, Lee and Shin 2007). Different 
structures and forms of PGA were already published 
ranging from foams to nanofibers. Non-woven PGA 
meshes were also used for chondrocyte proliferation in 
vitro and for extracellular matrix (ECM) production 
(Freed et al. 1994, Schaefer et al. 2000). However, 
inflammatory and nonbacterial foreign-body reactions of 
PGA in vivo were described in several studies (Bostman 
and Pihlajamaki 2000). These inflammatory reactions 
were probably caused by acid byproducts of PGA 
degradation (Athanasiou et al. 1995). Thus, combination 
of PGA with other material seems to be inevitable namely 
for a broader in vivo application.  
 A higher amount of poly(lactic acid) (PLA) 
reportedly diminishes PGA degradation both in vitro and 
in vivo (Lu et al. 1999, Lu et al. 2000). Buffers or 
different basic compounds, such as calcium carbonate, 
sodium bicarbonate, calcium hydroxyapatite, wollastine 
or bioglass 45S5, were also examined as an alternative 
approach for pH control of PGA-based implants 
(Agrawal and Athanasiou 1997, Ara et al. 2002, Day et 
al. 2004, Li and Chang 2005).  
 In the present study, biocompatibility of 
different novel PGA-based non-woven composite 
scaffolds was tested for chondrocyte adhesion and 
proliferation. Particular attention was devoted to the 
positive effect of a nontoxic, water-soluble, 
biocompatible and biodegradable synthetic polymer – 
polyvinyl alcohol (PVA), which is widely used in the 
biomedical field (Jia et al. 2007). In addition, hyaluronic 
acid (HA), a polysaccharide commonly present in 
synovial fluid and extracellular cartilage matrix, and 
chitosan, another natural biodegradable biopolymer, were 
applied in our non-woven composite scaffolds to 
compensate the negative inflammatory properties of PGA 
scaffolds and to prepare the optimum environment for 
chondrocyte seeding and for development of artificial 
cartilage. 
 
Materials and Methods 
 
Materials 
 The scaffolds were produced from poly(glycolic 
acid) (PGA) fibers (surgical thread from Chirmax, Ltd., 
Czech Republic, fiber average diameter 15 µm), 
polyvinyl alcohol (PVA) fibers (Kuralon K-II, Kuraray 
Europe GmbH, Germany, fiber average diameter 15 µm), 
and chitosan fibers (Weifang Young Deok Chitosan CO., 
LTD, China). Primary antibody against type II collagen 
(clone II-II6B3, DSHB, USA) and secondary antibody 
Cy 3-conjugated Donkey Anti-Mouse IgG (H+L) 
(Jackson ImmunoResearch) were used. 
 
Preparation of the scaffolds 
 The fiber scaffolds were prepared by the so-
called wet-laid process of non-woven production. The 
fibers were swollen and thoroughly dispersed in low 
voluminous concentration in various liquid media. The 
suspension was subsequently transported by a liquid flux 
on a screen, where a web was formed as a result of 
filtration-like process. The samples were finally dried and 
bonded.  
 There were prepared five different wet-laid non-
woven scaffolds with area density 283 g/m2:  
 PGA fibers were wet-laid in distilled water into 
a non-woven scaffold (PGA);  
 A blend of PGA fibers (50 %) and PVA fibers 
(50 %) was wet-laid in n-butanol and mechanically 
bonded by needle-punching (PGA/PVA);  
 A blend of PGA fibers (50 %) and PVA fibers 
(50 %) was wet-laid in n-butanol and consequently 
impregnated by distilled water. This solvent moderately 
dissolves PVA fibers that are unstable in water and thus 
PVA fibers served as a binder for the PGA ones 
(PVA/PGA/PVA);  
 PGA fibers were wet-laid in a water solution of 
0.1 % sodium hyaluronate (w/w) (Mr = 1.5 × 106 Da) 
(PGA/HA);  
 A blend of PGA fibers (1/3), PVA fibers (1/3) 
and chitosan fibers (1/3) was wet-laid in n-butanol and 
impregnated with distilled water. Dissolved PVA fibers 
served as a binder for PGA and chitosan fibers 
(PGA/PVA/CH). 
 Scaffolds were cut to circular pieces with a 
diameter of 6 mm and sterilized using hydrogen peroxide 
gas plasma. Sterilization by plasma was used because of 
PGA sensitivity to heat and moisture. In addition, 
hydrogen peroxide residuals are nontoxic and 
noncarcinogenic. 
 
Cells and cell culture conditions 
 Chondrocytes were isolated from the condyle of 
femur of a three-month-old New Zealand white rabbit 
under general anesthesia (60 mg/kg ketamine and 
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4 mg/kg xylazine). The cartilage was cut to small pieces 
(1 × 1 mm), put into a collagenase solution (0.9 mg/ml, 
collagenase crude 816 PSZ) and incubated in a 
humidified incubator (37 °C, 5 % CO2) for 14 h. Then the 
cells were centrifuged at 300 g for 5 min and seeded into 
culture flasks. The chondrocytes were cultivated in 
Iscove’s Modified Dulbecco’s Medium supplemented 
with 10 % fetal bovine serum (FBS), 
penicillin/streptomycin (100 IU/ml and 100 µg/ml, 
respectively), 400 mM L-glutamine, 100 nM 
dexamethasone, 40 µg/ml ascorbic acid-2-phosphate and 
ITS-X (10 µg/ml insulin, 5.5 mg/l transferrin, 6.7 µg/l 
sodium selenite, 2 mg/l ethanolamine. Chondrocytes were 
seeded on scaffolds at a density of 80 ×103 /cm2; the 
medium was changed every 3 days. 
 
Cell proliferation analysis by MTT test 
 The MTT test is widely used for in vitro 
measurement of the metabolic activity and proliferation 
of cells. MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-
2H-tetrazolium bromide] is reduced to purple formazan 
by mitochondrial dehydrogenase in cells indicating 
normal metabolism. 50 µl of MTT (1 mg/ml in a 
phosphate-buffered saline (PBS) pH 7.4) was added to 
the medium (150 µl) and samples were further incubated 
at 37 °C for 4 h. Formazan crystals were solubilized with 
100 μl of 50 % N,N-dimethylformamide/20 % sodium 
dodecyl sulfate (SDS) /H2O, pH 4.7. A volume of 200 µl 
of suspension was removed to the new well and the 
optical density of formazan was measured (λsample 570 nm, 
λreference 690 nm). Absorbance of samples incubated 
without cells was deducted from cell-seeded samples. 
Cells seeded on tissue culture plastic (TCP) were used as 
control. 
 
Fluorescence and confocal microscopy 
 Cells were stained using propidium iodide and 
visualized using fluorescence and confocal microscopy. 
Cells were fixed by frozen ethanol (–20 °C), rinsed with 
PBS and then propidium iodide (5 μg/ml in PBS) was 
added for 10 min, rinsed with PBS again and visualized 
using a confocal microscope (Leica SP2 AOBS 
(λexc=514 nm and λem=610-645 nm) and a fluorescence 
microscope (Olympus IX51, U-RFL-T).  
 Indirect immunofluorescence staining was used 
to detect type II collagen. Samples were fixed with 10 % 
formaldehyde/PBS for 10 min, washed in PBS and then 
incubated in 3 % FBS in PBS/0.1 % Triton at room 
temperature. Primary antibody (mouse anti type II 
collagen) was diluted 1:20 and added to samples for 
1 hour at room temperature. Then samples were washed 
with PBS/0.05 % Tween for 3, 10 and 15 min. Secondary 
antibody (Cy 3-conjugated Donkey Anti-Mouse IgG 
(H+L), was diluted 1:300 and added for 45 min at room 
temperature. After washing, an antifading solution was 
added (PBS/90 % glycerol/2.5 % 1,4-diazabicyclo(2,2,2) 
octane (DABCO). Type II collagen staining was 
visualized using confocal microscope Leica SP2 AOBS 
(λexc=488 nm, λem=555-620 nm).  
 
In vitro degradation of the scaffolds 
 The weight in dry and wet conditions, and water 
absorption of every group of scaffolds was measured. 
Three specimens of each group were dried to constant 
weight and weighed. Then each specimen was put into 
70 % ethanol for 10 min and then into PBS for 1 h. 
Surface water was wiped off with filter paper and the wet 
weight of samples was measured. Water absorption (WA) 
was calculated from the Eq. (1), 
 
WA = 100 × (Mw – Md)/Md ,  (1) 
 
where Mw is the weight in wet condition, Md in dry 
condition.  
 Five specimens of each group were used for pH 
measurement. Each sample was put into 20 ml of PBS in 
a separate bottle without stirring and refreshing. Samples 
were placed in an incubator (37 °C) and cultivated for 
42 days. The pH was measured every two days (pH-meter 
HANNA HI 92240). 
 
Statistics 
 Quantitative data were presented as mean ± SD 
(Standard Deviation). Results were evaluated statistically 
using one-way analysis of variance (ANOVA), and the 
Student-Newman-Keuls test. The level of significance 




Chondrocytes adhere well to wet-laid non-woven 
scaffolds from PGA 
 Chondrocyte adhesion on wet-laid non-woven 
scaffolds from different PGA mixtures was measured by 
the MTT test 24 h after seeding. In general, chondrocytes 
adhered well to all PGA-based scaffolds. The best 
adhesion (absorbance in MTT test A=0.41±0.06), was 
observed on both wet-laid non-woven scaffolds from 
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PGA without any additive (see Fig. 1) and the control 
TCP sample (A=0.47±0.04). The addition of PVA to the 
mixture significantly diminished chondrocyte adhesion, 
except PVA/PGA/PVA. Absorption of composite 
scaffolds from PVA/PGA/PVA decreased to 0.37±0.02 
and for PGA/PVA even to 0.32±0.02.  
 Curiously, the presence of hyaluronic acid in the 
PGA mixture did not improve cell adhesion. Absorption 
remained on the same statistical level with the PGA/PVA 
mixture (0.29±0.05). This rather surprising finding 
supports the results of fluorescence confocal microscopy 
where propidium iodide staining was used to visualize 
chondrocytes adhered on scaffold fibers (Fig. 2).  
 Presence of chitosan in the scaffold mixture 
resulted in the lowest chondrocyte adhesion of all the 
tested scaffolds. Absorption of the chitosan-containing 
scaffold (0.12±0.07) was significantly lower not only 
than the control sample but also than the PVA-containing 
scaffolds as well than the mesh from PGA/HA mixture. 
 
PVA but not hyaluronic acid improves chondrocyte 
proliferation on wet-laid non-woven scaffolds from PGA 
 Despite lower adhesion, the presence of PVA in 
wet-laid non-woven PGA scaffolds significantly 
improved chondrocyte proliferation. MTT tests 
performed on the 7th and 14th day after seeding indicated 
that the originally lower cell number adhering to fibers on 
the first day was significantly amplified by very good 
proliferation. Already 7 days after seeding, the highest 
cell number was observed on PVA/PGA (0.93±0.06). 
A somewhat lower value was observed after 7 days of 
cultivation on PVA/PGA/PVA and also on the control 
TCP (0.78±0.23 and 0.64±0.09, respectively). A lower 
absorbance 7 days after seeding was found for the PGA-
containing scaffold. Absorbance (0.33±0.16) was 
significantly lower both in the control TCP sample and in 
the PVA/PGA scaffold. Interestingly, the presence of 
hyaluronic acid did not improve chondrocyte 
proliferation at this early stage and, thus, a similar pattern 
and a significantly lower cell number compared to TCP 
and PVA containing scaffolds was observed also for the 
PGA /HA mixture (0.30±0.03).  
 In spite of the worst adhesion, the presence of 
chitosan in the wet-laid non-woven scaffold markedly 
improved proliferation. While 7 days after seeding our 
MTT test suggested a good proliferation (absorption 
0.45±0.01) but there was still no significant increase 
compared with the PGA or PGA/HA scaffolds, the 
PGA/PVA/CH showed a different outline after 14 days of 
cultivation. The amount of cells increased significantly 
(1.05±0.14 on day 14) and reached the same level as the 
control TCP sample (1.12±0.12) (Fig. 3).  
 This clearly suggested a positive effect of PVA 
but also chitosan presence in wet-laid non-woven 
scaffolds on chondrocyte proliferation.  
 
Confocal fluorescence microscopy of wet-laid non-woven 
scaffolds from PGA mixtures 
 The positive effect of PVA presence in wet-laid 
non-woven scaffolds from PGA mixtures on chondrocyte 
proliferation was proved by the MTT test. However, to 
confirm this conclusion and to verify suitable 
proliferation of chondrocytes along the fibers of wet-laid 
PVA-containing non-woven scaffolds, visualization by 
confocal microscopy was employed. Cells started to 
spread along the fibers already 7 days after seeding. On 
day 14 and 21, large proliferation of cells was observed, 
mainly on PGA/PVA/CH and PVA/PGA/PVA (Fig. 4).  
 A key point for successful preparation of 
artificial cartilage seems to be the preparation of 
chondrocytes in their optimum condition for 
transplantation. Only under these circumstances 
chondrocytes can produce the protein of extracellular 
matrix. Under these conditions, the production of type II 
collagen as typical extracellular marker for hyaline 
cartilage, was observed. Extracellular matrix started to be 
produced by proliferating chondrocytes on our wet-laid 
non-woven PGA/PVA scaffolds already during the first 
week after seeding. Using indirect immunofluorescence 
of anti-type II collagen, we visualized a developing 
extracellular matrix by confocal microscopy on days 7 
and 14 (Fig. 5). Increasing presence of type II collagen, 
as a marker of the hyaline cartilage extracellular matrix, 
is clearly demonstrated.  
 
Fig. 1. Chondrocyte adhesion (MTT test) one day after scaffold
seeding (significant differences between measured values are
described in the text; p<0.05).  
 




Fig. 3. Chondrocyte proliferation (MTT test) 7 and 14 days after 
scaffold seeding (significant differences between measured 
values are described in the text; p<0.05). 
 
 
Scaffolds containing PVA lead to pH stabilization 
 The time-dependent pH course in the incubation 
solution over a 42-day period was followed for all tested 
wet-laid non-woven scaffolds (Fig. 6). A significant pH 
drop for all PGA-containing scaffolds was found. The 
largest pH decrease was observed immediately after 
putting in solution. Despite the comparable initial pH 
decrease for all tested samples, medium acidification did 
not continue in the same manner. Acidification of the 
medium with scaffolds containing PVA continued only 
very moderately, especially for the PGA/PVA/CH. 
Conversely, samples containing only PGA or PGA in 
combination with HA prolonged considerable 
acidification over the whole 42-day period. This 
suggested a higher presence of degradation products in 
the incubation solution. 
 
Wettability of the scaffold influenced scaffold 
degradation 
 Slower scaffold degradation of composite PVA-
containing wet-laid non-woven scaffolds was also 
accompanied by another important characteristic: higher 
water retention inside the scaffolds. Presence of PVA in 
the mixture increased several times the water absorption 
in all wet-laid non-woven scaffolds (Table 1). The 
highest water retention was shown by the PVA/PGA 
scaffold, three times higher than the PGA scaffold. On 
the other hand, the addition of hyaluronic acid 
substantially lowered the water content in the scaffold 
compared to the PGA scaffold. Notably, samples 
characterized by higher water retention showed also less 
pronounced pH dependence. In addition, higher water 
retention in our samples correlates well not only with the 
pH dependence but also with improved chondrocyte 
proliferation while the decreased water content in the 





Chondrocytes adhere well but poorly proliferate on PGA 
non-woven textile mesh 
 Polyglycolic acid is commonly known as a 
resorbable substance frequently used in tissue 
engineering (Freed et al. 1994, Rokkanen et al. 2000, 
Schaefer et al. 2000, Lee and Shin 2007). Many different 
forms and structures of PGA were reported for 
application in regenerative medicine and tissue 
engineering but only a few reports are related to non-
woven PGA meshes and chondrocyte proliferation (Freed 
et al. 1994, Schaefer et al. 2000). In accordance with 
previously reported data, we found PGA non-woven 
textile mesh as a proper material for chondrocyte 
adhesion. Interestingly, presence of PGA in composite 
scaffolds seemed to be dominant for chondrocyte 
adhesion to non-woven textile mesh. Neither hyaluronic 
 
 
Fig. 2. Fluorescence and 
confocal microscopy –
chondrocyte adhesion on (a)
PGA/PVA and (b) PGA/HA 
scaffold one day after scaffold 
seeding. 
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acid nor chitosan nor PVA increased chondrocyte 
adhesion in any composite scaffold tested in the present 
study. Thus, our study confirmed the previously reported 
results that the mesh from polyglycolic acid (no matter 
whether in a single-component form or as a composite 
scaffold) is suitable material for chondrocyte adhesion. 
However, chondrocyte proliferation on wet-laid non-
woven PGA fibers significantly suffers from acidic 
degradation products. Naturally, hydrolysis of PGA 
causes its bulk degradation to glycolic acid which is 
followed by further transformation in the tricarboxylic 
acid cycle. Final degradation products are excreted as 
carbon dioxide and water (Athanasiou et al. 1995, 
Agrawal and Athanasiou 1997).  
 Elevated concentration of acidic by-products 
could be solved in vitro by pH control and/or incubation 
solution exchange. This approach, however, can be 
applied neither in vivo nor in vitro for composite 
scaffolds where mesh from polyglycolic acid is 
immobilized in gels or other similar materials. 
Nevertheless, these composite scaffolds attract growing 
attention particularly due to the possibility of tuning up 
their properties to make them more appropriate for cell 
seeding and proliferation. Consequently, better 
understanding of PGA degradation processes and 
especially improved knowledge of their modulation is 
highly important.  
 
Addition of PVA improves chondrocyte proliferation on 
PGA non-woven textile mesh 
 Although our composite scaffolds based on PGA 
non-woven textile mesh did not show any improved 
chondrocyte adhesion, their application in tissue 
engineering seems to be very promising. A proper 
additive can modify accordingly the biomechanical 
properties of the scaffold. Biomechanical properties are 
modified by presence of type II collagen as was detected 
in our study by immunofluorescence staining and 
subsequent visualization by confocal microscopy. Despite 
of less sensitivity of this method compared to PCR, type 
II collagen was detected in the vicinity of chondrocytes 
on day 7 and 14. There was a production of both type II 
collagen and glycosaminoglycans (GAG) which are 
typical indicators of chondrogenic character of cells that 
 
Fig. 4. Fluorescence confocal microscopy of proliferated chondrocytes. Chondrocytes are stained by propidium iodide, which is bound 
on cell DNA. Fibers of scaffold are also visible for their autofluorescence. PGA/PVA/CH scaffold – (a) 7, (b) 14, (c) 21 days after 
seeding, PVA/PGA/PVA scaffold – (d) 7, (e) 14, (f) 21 days after seeding. 
 
2010  Non-Woven PGA/PVA Scaffold for Chondrocyte Proliferation    779  
 
appear in conjunction. These components are synthesized 
by chondrocytes and diffused to the extracellular matrix 
(ECM) of hyaline cartilage. Joint synthesis of both GAG 
and type II collagen were commonly detected (Benya and 
Shaffer 1982, Vunjak-Novakovic et al. 1999, Deng et al. 
2003). Consequently, diffusion of type II collagen from 
chondrocytes as well as collagen crosslinking decreased 
by the inhibition of GAG incorporation in the newly 
formed ECM (Bastiaansen-Jenniskens et al. 2009).  
 Appropriate biomechanical properties of 
artificial scaffolds are currently a considerable obstacle in 
the construction of artificial cartilages. In addition, 
composite scaffolds can adjust the lifetime of 
biodegradation. Last but not least, apposite compounds 
can adapt scaffold biocompatibility. We clearly proved in 
our study a positive effect of PVA addition in wet-laid 
non-woven scaffolds from PGA on chondrocyte 
proliferation. A slightly lower chondrocyte adhesion in 
PVA-containing textile mesh was overcome already 
during the first week of incubation. Improved 
proliferation was also accompanied by a higher pH 
stability of incubation media. This suggested a moderate 
appearance of acidic biodegradation products in scaffolds 
resulting in a more favorable environment for 
chondrocyte proliferation. Notably, the presence of 
chitosan in wet-laid non-woven scaffolds from PGA/PVA 
did not significantly modify the positive effect of PVA on 
chondrocyte proliferation. However, such additives can 
modify the biomechanics and biodegradability of 
composite scaffolds. However, the influence of additives 
on these parameters could be only hardly predicted, as 
follows from the effect of hyaluronic acid which is one of 
the key substances of the hyaline extracellular matrix. 
Consequently, proper scaffold composition as well as the 
way of preparation remain to be experimentally tested.  
 Composite scaffold preparation is certainly an 
important feature dramatically influencing composite 
scaffold application. We found that the presence of PVA 
significantly increases water retention. This is one of the 
key points in the hypothetical explanation of improved 
chondrocyte proliferation – higher water retention leads 
to better supply of chondrocytes with nutrients and also 
 
 
Fig. 5. Fluorescence confocal 
microscopy of proliferated 
chondrocytes – immunofluorescent 
detection of type II collagen.
PVA/PGA/PVA scaffold (a) 7 and (b)
14 days after seeding. 
 
 
















PGA  4.2 ± 0.9 9.5 ± 1.6 141 ± 46 
PVA/PGA  4.4 ± 0.2 22.5 ± 1.2 416 ± 26 
PVA/PGA/PVA  4.5 ± 0.3 5.5 ± 0.6 23 ± 10 
PGA/HA  3.9 ± 0.5 6.7 ± 0.8 73 ± 13 
PGA/PVA/CH  5.3 ± 0.3 18.3 ± 2.3 242 ± 22 
 
For calculation details see Methods. 
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to a quicker disappearance of all kinds of degradation 
products. Such a scaffold structure needs a firmer 
connection between the fibers and has to be characterized 
by a more hydrophilic interior with larger pores for water 
penetration but also for cell seeding. Firmer and more 
solid scaffolds could be achieved either chemically or 
using physical means. Our attempts for a physical way of 
connection (mechanical puncturing) failed so far. 
However, we present here a successful chemical 
approach – an application of PVA as a suitable chemical 
fiber connection in wet-laid non-woven scaffolds from 
PGA.  
 
Chitosan but not hyaluronic acid is another component 
improving chondrocyte proliferation on PGA scaffolds 
 Besides PVA, we also tested the effect of other 
compounds that could improve chondrocyte seeding and 
proliferation, i.e. hyaluronic acid and chitosan. HA is a 
biocompatible and biodegradable polysaccharide which is 
a very common component of synovial fluid and 
extracellular matrix (ECM). It plays an important role in 
tissue hydration. HA is commonly used in medicine and 
tissue engineering for its physicochemical properties 
(Hahn et al. 2007) and was reported to improve in vitro 
substrate adhesion ability and proliferative activity of 
human chondrocytes (Patti et al. 2001). Interestingly, an 
attempt to apply HA in our PGA wet-laid non-woven 
composite scaffold with the aim of connecting PGA 
fibers failed. The presence of hyaluronic acid in the PGA 
mesh did not result in any improvement of chondrocyte 
proliferation compared to PVA scaffold. Notably, the 
presence of HA in our sample did not also improve water 
retention. This suggests that rather the size of pores and 
not the hydrophilicity of the surface component in wet-
laid non-woven scaffolds can play a crucial role for 
proper cell proliferation.  
 The presence of chitosan, however, resulted in 
different properties of the PGA composite scaffold. 
Chitosan is an at least partly deacetylated form of chitin, 
the second most abundant form of organic resource found 
in nature next to cellulose. These biopolymers have a 
good biocompatibility and biodegradation as well as 
various favorable antithrombogenic, homeostatic, 
immunity-enhancing or wound-healing properties (Jia et 
al. 2007). We applied chitosan in our PGA composite 
scaffold. While the presence of chitosan significantly 
deteriorated chondrocyte adhesion, chondrocyte 
proliferation was greatly enhanced after the first week, 
and especially during the second week of cultivation. 
Consequently, chitosan, beside PVA seems to be a 
promising compound for preparing composite scaffolds 
based on wet-laid non-woven PGA textile mesh intended 
for chondrocyte tissue engineering. However, it is 
necessary to state clearly that the properties of chitosan 
can sharply depend on its source and purity. 
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